GlassScriptPhysician profile
Lawrence Yenni
NPI 1609856905
$1,195.16
in general payments reported to CMS, 2019-2025
17 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $124 · 2021: $164 · 2022: $310 · 2023: $75.30 · 2024: $54.65 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.70 |
| Education | $101.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $448.31 | 2020-2025 | Persona |
| Trice Medical, INC. | $200.00 | 2019 | |
| Abbott Laboratories | $157.23 | 2022 | |
| Bioventus LLC | $66.02 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $60.00 | 2019-2025 | Pangea |
| Si-Bone, INC. | $54.73 | 2020-2022 | |
| Depuy Synthes Sales INC. | $34.50 | 2019-2023 | Motoband |
| Sanofi-Aventis U.S. LLC | $31.53 | 2019-2023 | |
| Smith+Nephew, INC. | $25.62 | 2019 | |
| Fidia Pharma USA INC. | $24.62 | 2022 | |
| Davol INC. | $20.79 | 2023 | |
| Heron Therapeutics, INC. | $18.80 | 2024 | Zynrelef |
| Ferring Pharmaceuticals INC. | $13.99 | 2023 | Euflexxa |
| Medtronic USA, INC. | $12.13 | 2019 | |
| Heraeus Medical, LLC. | $11.52 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $11.12 | 2019 | |
| Orthofix Medical, INC. | $4.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Yenni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.